{"schema_version":"1","generated_at":"2026-11-01T13:17:43.566Z","data_as_of":null,"url":"https://www.findmykol.com/kol/raphael-szalat","json_url":"https://www.findmykol.com/kol/raphael-szalat/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"raphael-szalat","name":"Raphael Szalat","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Boston University","institution_url":"https://www.findmykol.com/institution/boston-university","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1801394663","orcid":"0000-0002-6198-3405","openalex":"A5055748047"},"summary":"Raphael Szalat is an Oncology physician affiliated with Boston University. OpenAlex indexes 165 publications with 3,551 citations (h-index 29).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":165,"cited_by_count":3551,"h_index":29,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":5,"shown":3,"withheld":2,"rows":[{"payer":"Kite Pharma, Inc.","program_year":2025,"amount_usd":31.8,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1801394663"},{"payer":"Janssen Scientific Affairs, LLC","program_year":2024,"amount_usd":3025,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1801394663"},{"payer":"Janssen Scientific Affairs, LLC","program_year":2023,"amount_usd":840,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1801394663"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1801394663","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":45.8,"classes_total":1,"classes":[{"class":"Thalidomide Analog","setting":"prescribed","share_pct":45.8,"drugs":[{"name":"Revlimid","share_pct":100}],"max_beneficiaries":null}]},{"area":"Dermatology","share_pct":33.6,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":33.6,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":20.6,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":20.6,"drugs":[{"name":"Eliquis","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Role of minimal residual disease assessment in multiple myeloma","year":2024,"journal":"Haematologica","source_url":"https://doi.org/10.3324/haematol.2023.284662","status":"verified"},{"title":"Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain Amyloidosis","year":2024,"journal":"JAMA Oncology","source_url":"https://doi.org/10.1001/jamaoncol.2024.2629","status":"verified"},{"title":"Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes","year":2024,"journal":"Nature Communications","source_url":"https://doi.org/10.1038/s41467-024-47793-5","status":"verified"},{"title":"High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma","year":2023,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2022017094","status":"verified"},{"title":"Single-Cell Profiling in Multiple Myeloma: Insights, Problems, and Promises","year":2023,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2022017145","status":"verified"}],"source":"works"},"contact":{"address_1":"830 HARRISON AVENUE, 3RD FL","address_2":"MOAKLEY BLDG","city":"Boston","state":"MA","zip":"021182905","phone":"617-638-6428","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1801394663","source":"identity"},"similar":[{"name":"David Felson","slug":"david-felson","institution":"Boston University","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/david-felson","json_url":"https://www.findmykol.com/kol/david-felson/profile.json"},{"name":"Gary Balady","slug":"gary-balady","institution":"Boston University","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/gary-balady","json_url":"https://www.findmykol.com/kol/gary-balady/profile.json"},{"name":"Andrew Budson","slug":"andrew-budson","institution":"Boston University","specialty":"Neurology","url":"https://www.findmykol.com/kol/andrew-budson","json_url":"https://www.findmykol.com/kol/andrew-budson/profile.json"},{"name":"Davidson Hamer","slug":"davidson-hamer","institution":"Boston University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/davidson-hamer","json_url":"https://www.findmykol.com/kol/davidson-hamer/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":2,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2026-05-20","provider_certified":"2026-05-20","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}